Social Anxiety Disorder (SAD/Social Phobia) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Social Anxiety Disorder (SAD/Social Phobia) Clinical Trials Market Report Overview
There were a total of 345 social anxiety disorder clinical trials conducted as of August 2023. The social anxiety disorder clinical trial market research report provides a comprehensive overview of the market across regions and countries (G7 & E7). It also provides insights into the various phases, trial status, and end points status. The report includes information about the sponsor types and the prominent sponsors associated with the trials as well.
Social Anxiety Disorder Clinical Trials Market Segmentation by Regions
A few of the key regions where social phobia clinical trials are conducted are North America, Europe, Asia-Pacific, Middle East & Africa, and South & Central America, among others. As of August 2023, North America accounted for the highest share of the regional landscape. Sponsors conducted more than 35% of the trials in this region.
Social Anxiety Disorder Clinical Trials Analysis by Regions, 2023 (%)
Buy the Full Report for More Regional Insights into the Social Anxiety Disorder Clinical Trials Market
Key Regions | · North America
· Europe · Asia-Pacific · Middle East & Africa · South & Central America |
Key Countries | · The US
· Canada · Russia · Iran · China
|
Leading Sponsors | · GSK plc
· The Lundbeck Foundation · Viatris Inc · Johnson & Johnson · VistaGen Therapeutics Inc |
Key Sponsor Types | · Company
· Institution · Government |
Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
Social Anxiety Disorder Clinical Trials Market Segmentation by Countries
- Country Insights
The US had the highest number of social anxiety disorder clinical trials, as of August 2023. Meanwhile, Spain had the highest average patient enrollment as of August 2023.
- G7 Countries
Among the G7 (US, UK, Germany, France, Italy, Canada, and Japan) countries, Canada had the highest proportion of social anxiety disorder to central nervous system clinical trials as of August 2023.
- E7 countries
Among the E7 (Brazil, Russia, India, China, Mexico, Turkey, and Indonesia) countries, Russia had the highest proportion of social anxiety disorder to central nervous system clinical trials as of August 2023.
Social Anxiety Disorder Clinical Trials Analysis by Countries, 2023 (%)
Buy the Full Report for More Country Insights into the Social Anxiety Disorder Clinical Trials Market
Social Anxiety Disorder Clinical Trials Market - Competitive Landscape
A few of the leading sponsors associated with the social phobia market are:
- GSK plc
- The Lundbeck Foundation
- Viatris Inc
- Johnson & Johnson
- VistaGen Therapeutics Inc
GSK plc conducted the highest number of social anxiety disorder clinical trials in 2023.
Social Anxiety Disorder Clinical Trials Market Analysis by Sponsors, 2023 (%)
Buy the Full Report for More Sponsor Insights into the Social Anxiety Disorder Clinical Trials Market
Social Anxiety Disorder Clinical Trials Market Segmentation by Sponsor Types
The key sponsor types in the market are companies, institutions, and the government. Out of them, the company segment dominated the market in August 2023.
Social Anxiety Disorder Clinical Trials Market Analysis by Sponsor Types, 2023 (%)
Buy the Full Report for More Sponsor Type Insights into the Social Anxiety Disorder Clinical Trials Market
Segments Covered in the Report
Social Anxiety Disorder Clinical Trials Regional Outlook (2023)
- North America
- Europe
- Asia-Pacific
- Middle East and Africa
- South and Central America
Social Anxiety Disorder Clinical Trials Country Outlook (2023)
- The US
- Canada
- Russia
- Iran
- China
Social Anxiety Disorder Clinical Trials Regional Outlook (2023)
- Company
- Institution
- Government
Scope
- The report provides a snapshot of the global clinical trials landscape.
- The report provides top-level data related to the clinical trials by region, country (G7 & E7), trial status, trial phase, sponsor type, and end-point status.
- The report reviews the top companies involved and enlists all trials pertaining to the company.
- The report provides all the unaccomplished trials with reasons for unaccomplishment.
- The report provides enrollment trends for the past five years.
- The report provides the latest news for the past three months.
Reasons to Buy
- Assists in formulating key business strategies with regards to investment.
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost.
- Provides top-level analysis of the Global Clinical Trials Market which helps in identifying key business opportunities.
- Supports understanding of trial count and enrollment trends by country in the global therapeutics market.
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted trials.
- Facilitates clinical trial assessment of the indication on a global, regional, and country level.
The Lundbeck Foundation
Viatris Inc
Johnson & Johnson
VistaGen Therapeutics Inc
Novartis AG
Pfizer Inc
AbbVie Inc
AstraZeneca Plc
Aurobindo Pharma Ltd
Table of Contents
Table
Figures
Frequently asked questions
-
Which region accounted for the highest number of social anxiety disorder clinical trials in August 2023?
North America accounted for the highest number of social anxiety disorder clinical trials as of August 2023.
-
Which country conducted the highest number of social anxiety disorder clinical trials in August 2023?
The US conducted the highest number of social anxiety disorder clinical trials as of August 2023.
-
Which sponsor type was the most prominent in the social anxiety disorder clinical trials in August 2023?
As of August 2023, the company sponsor type conducted most of the social anxiety disorder clinical trials.
-
Which are the leading sponsors of social anxiety disorder clinical trials?
A few of the leading sponsors of social anxiety disorder clinical trials are GSK plc, The Lundbeck Foundation, Viatris Inc., Johnson & Johnson, and VistaGen Therapeutics Inc., among others.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.